Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

Nature. 1990 May 17;345(6272):258-60. doi: 10.1038/345258a0.

Abstract

Specific B lymphocytes can act as very efficient antigen-presenting cells. They bind antigen with high affinity via their immunoglobulin receptors, process it through the class II major histocompatibility complex (MHC) pathway, and present its fragments to class II-restricted T lymphocytes. In general, exogenous antigens and noninfectious viral particles enter the class II pathway and are selectively associated with class II MHC molecules. The presentation of an exogenous antigen in association with class I molecules has been reported for only a few antigens, including the hepatitis B envelope antigen (HBenvAg). Here we demonstrate that antigen-specific B cells can efficiently deliver HBenvAg to the class I pathway, presenting its fragments to class I-restricted cytotoxic T lymphocytes (CTLs) which kill the specific B cells. This could represent a mechanism of suppression of neutralizing anti-hepatitis B virus (HBV) antibody response, a phenomenon that accompanies the development of the chronic HBV-carrier state.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Antigens, CD / immunology
  • Antigens, Differentiation, T-Lymphocyte / immunology
  • B-Lymphocytes / immunology*
  • CD4 Antigens / immunology
  • CD8 Antigens
  • Cell Line
  • Clone Cells
  • Cytotoxicity, Immunologic*
  • HLA-DR Antigens / immunology
  • Hepatitis B / immunology
  • Hepatitis B Antigens / immunology*
  • Histocompatibility Antigens Class I / immunology*
  • Humans
  • Major Histocompatibility Complex
  • T-Lymphocytes / immunology*
  • Viral Envelope Proteins / immunology*

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • CD4 Antigens
  • CD8 Antigens
  • HLA-DR Antigens
  • Hepatitis B Antigens
  • Histocompatibility Antigens Class I
  • Viral Envelope Proteins